Cost-effectiveness of cladribine tablets for the treatment of active relapsing-remitting multiple sclerosis in the United Kingdom.

Jones M, Alexopoulos ST, Fontrier A-M, Harty G, Libanore A

Curr Med Res Opin. 2026 Oct 22:1-17. PMID: 42908358. Abstract